Investigation of Certain Allegations Related to Voting on the Medicare Prescription Drug, Improvement, and Modernization Act of 2003

Members involved

• Nick Smith (R-MI)

Statement

On March 17, 2004, the Committee adopted a resolution which established an Investigative Subcommittee to investigate alleged communications received by Representative Nick Smith linking support for the congressional candidacy of his son with Representative Smith’s vote on the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Representative Kenny C. Hulshof served as Chairman of the Investigative Subcommittee, and Representative Michael F. Doyle served as the Ranking Minority Member. Representative John B. Shadegg and Representative William D. Delahunt were the other two Members of the Investigative Subcommittee. By unanimous vote on September 30, 2004, the Committee on Standards of Official Conduct approved and adopted the Report of the Investigative Subcommittee in the above-referenced matter. The Investigative Subcommittee had broad authority to investigate this matter, as set forth in the resolution adopted by the Committee. The evidence obtained by the Investigative Subcommittee in the course of carrying out its responsibilities included the sworn testimony of 17 Members of the House (including Speaker J.

Documents

• Statement on ethics.house.gov
• Document 1 (PDF)

More

• All House ethics statements